Active Ingredient(s): Cladribine
FDA Approved: * February 26, 1993
Pharm Company: * ORTHO BIOTECH
Category: Cancer

Cladribine, sold under the brand name Leustatin, among others, is a medication used to treat hairy cell leukemia (leukemic reticuloendotheliosis) and B-cell chronic lymphocytic leukemia.[5][6] cladribine, sold under the brand name Mavenclad, is indicated for the treatment of adult patients with highly active forms of relapsing-remitting multiple sclerosis.[7] Cladribine (2-chloro-2'-deoxyadenosine [2-CdA]) is a purine analogue that selectively t... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Leustatin 1 mg/ml Intravenous Injection, Solution
NDC: 59676-201
Janssen Products, L.p.

Related Brands

Drugs with the same active ingredients